C2i Genomics Raises $100 Million To Commercialize the Detection of Tiny Traces of Cancer Using AI and Whole Genome Sequencing
Similar Posts
Community Care Collaborative Selects Bridge Patient Portal for Patient-Centered Engagement, Spanish Translation and Responsive Mobile Design
Texas Healthcare Organization Achieves Twice the National Patient Enrollment Average Using Bridge Patient Portal Serving the 11th largest metro-area in the…
HIMSS Media Lab is Launched to Lift Audience Engagement and Revenue
Promises to Deliver Scientific Approach to Marketing Analysis and Content Development HIMSS Media has launched the Media Lab to…
Brighter Teams with Sanmina to Manufacture Actiste
Brighter, a solution provider focused on data-driven, mobile health services, announced a partnership with Sanmina to produce the first…
First Scientifically Validated Symptom Checker with Artificial Intelligence Launches in the United States
Mediktor combines artificial intelligence, natural language recognition technologies and patient data to detect symptoms and offer a listing of…
Bruyere Continuing Care is the First Canadian Customer of Diabetes Self-Management Program from Canary Health and Medtronic
Recently Redesigned Better Choices, Better Health® Program Proven to Help Individuals Manage Their Chronic Condition LOS ANGELES – June 1,…
